| Primary |
| Immunosuppressant Drug Therapy |
38.9% |
| Rheumatoid Arthritis |
16.7% |
| Systemic Lupus Erythematosus |
16.7% |
| Coeliac Disease |
11.1% |
| Acute Graft Rejection |
5.6% |
| Acute Lymphocytic Leukaemia |
5.6% |
| Thrombocytopenia |
5.6% |
|
| Pneumocystis Jiroveci Pneumonia |
33.3% |
| Mycobacterial Infection |
16.7% |
| T-lymphocyte Count Increased |
16.7% |
| Transplant Rejection |
16.7% |
| White Blood Cell Count Decreased |
16.7% |
|
| Secondary |
| Hodgkin's Disease |
24.6% |
| Product Used For Unknown Indication |
20.5% |
| Acute Lymphocytic Leukaemia |
10.1% |
| Peripheral T-cell Lymphoma Unspecified |
6.7% |
| Diffuse Large B-cell Lymphoma |
5.2% |
| Non-hodgkin's Lymphoma |
4.9% |
| Lymphoma |
3.7% |
| Lymphoblastic Lymphoma |
3.0% |
| Immunosuppression |
2.6% |
| Malignant Lymphoid Neoplasm |
2.2% |
| Chronic Lymphocytic Leukaemia |
1.9% |
| Hypertension |
1.9% |
| Immunosuppressant Drug Therapy |
1.9% |
| Mycosis Fungoides |
1.9% |
| T-cell Lymphoma |
1.9% |
| Takayasu's Arteritis |
1.9% |
| Dermatomyositis |
1.5% |
| Pain |
1.5% |
| Graves' Ophthalmopathy |
1.1% |
| Hepatitis C |
1.1% |
|
| Weight Increased |
19.5% |
| Weight Decreased |
12.2% |
| Pulmonary Embolism |
7.3% |
| White Blood Cell Count Decreased |
7.3% |
| Gastrointestinal Infection |
4.9% |
| No Therapeutic Response |
4.9% |
| Oral Candidiasis |
4.9% |
| Renal Failure Acute |
4.9% |
| Transaminases Increased |
4.9% |
| Walking Aid User |
4.9% |
| Acanthamoeba Infection |
2.4% |
| Blood Glucose Increased |
2.4% |
| Cardio-respiratory Distress |
2.4% |
| Crohn's Disease |
2.4% |
| Death |
2.4% |
| Dysstasia |
2.4% |
| Electrocardiogram Change |
2.4% |
| Epilepsy |
2.4% |
| General Physical Health Deterioration |
2.4% |
| Herpes Zoster |
2.4% |
|
| Concomitant |
| Plasma Cell Myeloma |
24.3% |
| Prostate Cancer Metastatic |
8.6% |
| Systemic Lupus Erythematosus |
8.6% |
| Product Used For Unknown Indication |
8.0% |
| Immunodeficiency Common Variable |
7.6% |
| Osteoporosis |
6.0% |
| Multiple Sclerosis |
5.0% |
| Chronic Myeloid Leukaemia |
4.0% |
| Myelodysplastic Syndrome |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Renal Transplant |
3.0% |
| Acute Lymphocytic Leukaemia |
2.3% |
| Acute Myeloid Leukaemia |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Antiretroviral Therapy |
2.0% |
| Diffuse Large B-cell Lymphoma |
2.0% |
| Hypertension |
2.0% |
| Relapsing-remitting Multiple Sclerosis |
2.0% |
| Hiv Infection |
1.7% |
| Myelofibrosis |
1.7% |
|
| Vomiting |
14.7% |
| Pneumonia |
11.5% |
| White Blood Cell Count Decreased |
9.6% |
| Weight Decreased |
8.3% |
| Pain In Extremity |
5.1% |
| Upper Respiratory Tract Infection |
4.5% |
| Urinary Tract Infection |
4.5% |
| Platelet Count Decreased |
3.8% |
| Rash |
3.8% |
| Death |
3.2% |
| Disease Progression |
3.2% |
| Nausea |
3.2% |
| Pain |
3.2% |
| Sepsis |
3.2% |
| Stress Fracture |
3.2% |
| Syncope |
3.2% |
| Thrombosis |
3.2% |
| Weight Increased |
3.2% |
| Condition Aggravated |
2.6% |
| Hypertension |
2.6% |
|
